These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30027849)

  • 1. Role of Noncoding RNA in Pulmonary Arterial Hypertension and Potential Drug Therapeutic Target.
    Zhang CY; Liu M; Wan JM; Gao MQ; Zhang Y; Soyan M; Wang HL; Bai Y
    Curr Top Med Chem; 2018; 18(12):975-986. PubMed ID: 30027849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical effects of epigenetic regulation in pulmonary arterial hypertension.
    Chen D; Gao W; Wang S; Ni B; Gao Y
    Cell Mol Life Sci; 2017 Oct; 74(20):3789-3808. PubMed ID: 28573430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on the epigenetic mechanisms underlying pulmonary arterial hypertension.
    Luna RCP; de Oliveira Y; Lisboa JVC; Chaves TR; de Araújo TAM; de Sousa EE; Miranda Neto M; Pirola L; Braga VA; de Brito Alves JL
    Braz J Med Biol Res; 2018 Oct; 51(12):e7437. PubMed ID: 30365723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives.
    Bernardi N; Bianconi E; Vecchi A; Ameri P
    Heart Fail Clin; 2023 Jan; 19(1):137-152. PubMed ID: 36435569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs in PAH: biomarker, therapeutic target or both?
    Meloche J; Pflieger A; Vaillancourt M; Graydon C; Provencher S; Bonnet S
    Drug Discov Today; 2014 Aug; 19(8):1264-9. PubMed ID: 24881781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery.
    Vaidya B; Gupta V
    J Control Release; 2015 Aug; 211():118-33. PubMed ID: 26036906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs: promising therapeutic targets for the treatment of pulmonary arterial hypertension.
    Yuan K; Orcholski M; Tian X; Liao X; de Jesus Perez VA
    Expert Opin Ther Targets; 2013 May; 17(5):557-64. PubMed ID: 23379818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25(OH)
    Yu H; Xu M; Dong Y; Liu J; Li Y; Mao W; Wang J; Wang L
    Exp Cell Res; 2018 Jan; 362(2):311-323. PubMed ID: 29196166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension.
    Kim JD; Lee A; Choi J; Park Y; Kang H; Chang W; Lee MS; Kim J
    Exp Mol Med; 2015 Jul; 47(7):e175. PubMed ID: 26228095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.
    Ranasinghe ADCU; Schwarz MA
    Biochem Pharmacol; 2022 Oct; 204():115245. PubMed ID: 36096239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA networks in pulmonary arterial hypertension: share mechanisms with cancer?
    Courboulin A; Ranchoux B; Cohen-Kaminsky S; Perros F; Bonnet S
    Curr Opin Oncol; 2016 Jan; 28(1):72-82. PubMed ID: 26569423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBV Noncoding RNAs.
    Skalsky RL; Cullen BR
    Curr Top Microbiol Immunol; 2015; 391():181-217. PubMed ID: 26428375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-Coding RNA in the Pathogenesis, Progression and Treatment of Hypertension.
    Leimena C; Qiu H
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics meets epigenetics: Genetic variants that modulate noncoding RNA in cardiovascular diseases.
    Calore M; De Windt LJ; Rampazzo A
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):27-34. PubMed ID: 26546166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA (Epi)genetics in cardiovascular diseases.
    Elia L; Condorelli G
    J Mol Cell Cardiol; 2015 Dec; 89(Pt A):11-6. PubMed ID: 26205296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Coding RNA Networks in Pulmonary Arterial Hypertension.
    Chen B; Xia Y; Jiang Y; Sun Z; Zhang Y; Liu Y
    Pharmacology; 2024 Sep; ():1-12. PubMed ID: 39342938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in treatment of pulmonary arterial hypertension: patent review.
    Vaidya B; Pangallo M; Ruffenach G; Cunningham CM; Perron JC; Kolluru S; Eghbali M; Gupta V
    Expert Opin Ther Pat; 2017 Aug; 27(8):907-918. PubMed ID: 28355094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New meaning in the message: noncoding RNAs and their role in retinal development.
    Rapicavoli NA; Blackshaw S
    Dev Dyn; 2009 Sep; 238(9):2103-14. PubMed ID: 19191220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in pulmonary arterial hypertension: pathogenesis, diagnosis and treatment.
    Bienertova-Vasku J; Novak J; Vasku A
    J Am Soc Hypertens; 2015 Mar; 9(3):221-34. PubMed ID: 25660363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.